| Osteoporosis |
1 |
1 |
| Fractures |
0 |
0.99 |
| Bisphosphonate |
0 |
0.72 |
| Spinal Fractures and Dislocations |
0 |
0.55 |
| Bone |
0 |
0.31 |
| Grant |
0 |
0.31 |
| Adverse Effects |
0 |
0.21 |
| Endocrinology |
0 |
0.21 |
| Stress |
0 |
0.21 |
| Selective Estrogen Receptor Modulators |
0 |
0.18 |
| Health Insurance |
0 |
0.15 |
| Patient Safety |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.13 |
| Biomedical Technology |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Estrogen |
0 |
0.1 |
| Femoral |
0 |
0.1 |
| Generics |
0 |
0.1 |
| Hand |
0 |
0.1 |
| Hip Fracture |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Insurance |
0 |
0.1 |
| Jaw |
0 |
0.1 |
| Metabolism |
0 |
0.1 |
| Receptors |
0 |
0.1 |
| Travel Medicine |
0 |
0.1 |
| Vertebral Fracture |
0 |
0.1 |
| Virginia |
0 |
0.1 |
| Biologic Therapy |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |